|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Tom Brody (Contract Researcher, Baker Hostetler, San Francisco, CA, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc ISBN: 9780128146477ISBN 10: 0128146478 Pages: 656 Publication Date: 20 December 2017 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Forthcoming Availability: Not yet available ![]() This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of Contents1. Introduction2. FDA's decision-making process when assessing ambiguous data3. Food effect studies4. Dose modification and dose titration5. Contraindications6. Animal studies7. Drug-drug interactions -- Part One (small molecule drugs)8. Drug-drug interactions -- Part Two (therapeutic proteins)9. Immunosuppression, drug-induced hypersensitivity reactions, and drug-induced autoimmune reactions10. Drug class analysis11. Relatedness12. Adjudication of clinical data13. Coding14. PoolingReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |